WO2005065650A3 - Formulations - Google Patents
Formulations Download PDFInfo
- Publication number
- WO2005065650A3 WO2005065650A3 PCT/GB2004/004241 GB2004004241W WO2005065650A3 WO 2005065650 A3 WO2005065650 A3 WO 2005065650A3 GB 2004004241 W GB2004004241 W GB 2004004241W WO 2005065650 A3 WO2005065650 A3 WO 2005065650A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carboxylic acid
- acid surfactant
- aerosol formulations
- surfactant
- pharmaceutical formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006530593A JP2007508283A (ja) | 2003-10-09 | 2004-10-06 | カルボン酸界面活性剤を含むエアロゾル製剤 |
EP04820961A EP1684721A2 (fr) | 2003-10-09 | 2004-10-06 | Formulations d'aerosol comprenant un tensio actif d'un acide carboxylique |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0323701.3A GB0323701D0 (en) | 2003-10-09 | 2003-10-09 | Formulations |
GB0323701.3 | 2003-10-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005065650A2 WO2005065650A2 (fr) | 2005-07-21 |
WO2005065650A3 true WO2005065650A3 (fr) | 2006-04-27 |
Family
ID=29433610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2004/004241 WO2005065650A2 (fr) | 2003-10-09 | 2004-10-06 | Formulations |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1684721A2 (fr) |
JP (1) | JP2007508283A (fr) |
GB (1) | GB0323701D0 (fr) |
WO (1) | WO2005065650A2 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GT200500281A (es) | 2004-10-22 | 2006-04-24 | Novartis Ag | Compuestos organicos. |
GB0424284D0 (en) | 2004-11-02 | 2004-12-01 | Novartis Ag | Organic compounds |
GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
KR20080036632A (ko) | 2005-08-08 | 2008-04-28 | 아젠터 디스커버리 리미티드 | 바이시클로[2.2.1]헵트-7-일아민 유도체 및 이들의 용도 |
GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
PT2322525E (pt) | 2006-04-21 | 2013-12-26 | Novartis Ag | Derivados de purina para utilização como agonistas do recetor de adenosina a2a |
AU2009203693B2 (en) | 2008-01-11 | 2012-06-07 | Novartis Ag | Pyrimidines as kinase inhibitors |
US8236786B2 (en) | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
EA019441B1 (ru) | 2008-12-30 | 2014-03-31 | Палмаджен Терепьютикс (Инфлеммейшн) Лимитед | Сульфонамиды, предназначенные для лечения респираторных нарушений |
WO2010150014A1 (fr) | 2009-06-24 | 2010-12-29 | Pulmagen Therapeutics (Inflammation) Limited | Glitazones 5r-5–deutérés pour le traitement de maladies respiratoires |
GB0918922D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminopyridine derivatives |
GB0918924D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Azaindole derivatives |
GB0918923D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminothiazole derivatives |
WO2011098746A1 (fr) | 2010-02-09 | 2011-08-18 | Pulmagen Therapeutics (Inflammation) Limited | Sels d'addition acide cristallins de l'énantiomère (5r) de la pioglitazone |
GB201002224D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
GB201002243D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
WO2012034095A1 (fr) | 2010-09-09 | 2012-03-15 | Irm Llc | Composés et compositions comme inhibiteurs de trk |
UY33597A (es) | 2010-09-09 | 2012-04-30 | Irm Llc | Compuestos y composiciones como inhibidores de la trk |
SG192795A1 (en) | 2011-02-25 | 2013-09-30 | Irm Llc | Compounds and compositions as trk inhibitors |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002012265A1 (fr) * | 2000-08-05 | 2002-02-14 | Glaxo Group Limited | 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYLE) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYLE-3-OXO-ANDROST-1,4,-DIENE-17-ACIDE CARBOTHIOIQUE S-FLUOROMETHYLE ESTER UTILISE COMME AGENT ANTI INFLAMMATOIRE |
WO2002066422A1 (fr) * | 2001-02-14 | 2002-08-29 | Glaxo Group Limited | Derives de phenethanolamine pour le traitement de maladies respiratoires |
WO2003013610A2 (fr) * | 2001-08-03 | 2003-02-20 | Glaxo Group Limited | Composes d'agents de surface et leurs utilisations |
-
2003
- 2003-10-09 GB GBGB0323701.3A patent/GB0323701D0/en not_active Ceased
-
2004
- 2004-10-06 WO PCT/GB2004/004241 patent/WO2005065650A2/fr active Application Filing
- 2004-10-06 EP EP04820961A patent/EP1684721A2/fr not_active Withdrawn
- 2004-10-06 JP JP2006530593A patent/JP2007508283A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002012265A1 (fr) * | 2000-08-05 | 2002-02-14 | Glaxo Group Limited | 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYLE) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYLE-3-OXO-ANDROST-1,4,-DIENE-17-ACIDE CARBOTHIOIQUE S-FLUOROMETHYLE ESTER UTILISE COMME AGENT ANTI INFLAMMATOIRE |
WO2002066422A1 (fr) * | 2001-02-14 | 2002-08-29 | Glaxo Group Limited | Derives de phenethanolamine pour le traitement de maladies respiratoires |
WO2003013610A2 (fr) * | 2001-08-03 | 2003-02-20 | Glaxo Group Limited | Composes d'agents de surface et leurs utilisations |
Also Published As
Publication number | Publication date |
---|---|
WO2005065650A2 (fr) | 2005-07-21 |
GB0323701D0 (en) | 2003-11-12 |
JP2007508283A (ja) | 2007-04-05 |
EP1684721A2 (fr) | 2006-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005065650A3 (fr) | Formulations | |
AU2003239609A1 (en) | 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same | |
AU2206801A (en) | Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate | |
WO2005063231A3 (fr) | Formulation contenant un acide carboxylique ou un ester de celui-ci | |
PL368129A1 (en) | Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient | |
TNSN04148A1 (en) | Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect | |
WO2007014124A3 (fr) | Formes posologiques et preparations a charge medicamenteuse elevee | |
IT1320176B1 (it) | Dispersioni solide di principi attivi nitrati. | |
CA2317999A1 (fr) | Formulation pharmaceutique de propionate de fluticasone | |
AU2001278772A1 (en) | Benzoic acid derivatives and drugs containing the same as the active ingredient | |
WO2005011614A3 (fr) | Combinaison de deshydroepiandrosterone ou de sulfate de deshydroepiandrosterone avec un anticorps anti-ige pour le traitement de l'asthme ou de la bronchopneumopathie obstructive chronique | |
WO2006061155A3 (fr) | Stabilisation d'esters de glucocorticoides au moyen d'acides | |
AU2001234107A1 (en) | Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient | |
WO2004094373A3 (fr) | Procede d'administration de steroide a un niveau benefique avec un inhibiteur de la cyclo-oxygenase-2 et compositions correspondantes | |
MXPA03001752A (es) | Uso de la combinacion de salmeterol y propionato de fluticasona. | |
AU2002237400A1 (en) | Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate | |
WO2002059147A3 (fr) | Peptides armes | |
WO2007008427A3 (fr) | Compositions aerosol et procedes | |
PT1666473E (pt) | Compostos ácido carboxílico e composições medicinais que os contêm como ingrediente activo | |
AU2003232874A1 (en) | A pharmaceutical composition comprising a corticosteroid and a nonsterodial anti-inflammatory agent | |
AU4884701A (en) | Malonanilic acid derivatives, medicinal compositions containing the same and usethereof | |
AU2003289782A1 (en) | Valproic acid analogues and pharmaceutical compositions thereof | |
AU2003222565A1 (en) | The pharmaceutical composition comprising a corticosteroid and an antiseptic | |
BG106368A (en) | Pharmaceutical composition and its preparation | |
WO2001030372A3 (fr) | Preparations de principes actifs pharmaceutiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006530593 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004820961 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004820961 Country of ref document: EP |